| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |